haliclonadiamine and Kidney-Neoplasms

haliclonadiamine has been researched along with Kidney-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for haliclonadiamine and Kidney-Neoplasms

ArticleYear
Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges.
    Journal of natural products, 2012, Sep-28, Volume: 75, Issue:9

    Renal or kidney cancer accounts for about 3% of all cancer cases reported each year in the U.S. Molecular signatures that define the cancer, such as the loss of functional VHL, are found in both sporadic and familial cases of cancer. In clear cell renal cancer, the transcription factor HIF-2α has been shown to have a distinct role in tumorigenesis. Our laboratories developed a cell-based screen to identify modulators of HIF-2α. Screening of the NCI's Natural Product Extract Repository resulted in the identification of 10 sponge extracts, from which 12 compounds were isolated. The biological evaluation of these compounds will be discussed including evaluation of HIF-1α vs HIF-2α selectivity and the isolated compounds' effects on mRNA from several pathways regulated by HIF.

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Biological Products; Humans; Kidney Neoplasms; Marine Biology; Molecular Structure; Porifera; RNA, Messenger

2012